Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
株式のランク #38668
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
株価
$0.04057595
最終同期: 2024-08-05
時価総額
$863.62K
変化(1日)
0.31%
変化(1年)
0.00%
SE
取引 AegirBio AB (publ) (AEGIR)

カテゴリー

AegirBio AB (publ)(AEGIR)のP/B比率
August 2026 時点のP/B比率 TTM: -7.38
AegirBio AB (publ) の最新の財務報告および株価によると、現在のP/B比率(TTM)は -7.38 です。2022 年末時点でのP/B比率は 0.97 でした。
AegirBio AB (publ) の P/B 比率の履歴(2019 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
2026 (TTM) -7.38 -63.41%
2023 -20.17 -2,180.89%
2022 0.97 -61.61%
2021 2.53 -61.19%
2020 6.51 -92.78%
2019 90.12 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差
6.8941 -193.42%
US
1.9293 -126.14%
FR
- -
JP
1.926 -126.10%
US
- -
CH